Company
United StatesPublic company, NASDAQ: LINLinde Inc (NASDAQ: LIN), Garland, TX – FDA Inspections
Inspection records and compliance data for Linde Inc in Garland, Texas. 2 FDA inspections on record, 1 Form 483, last inspected May 22, 2026. Publicly traded as NASDAQ: LIN.
Company Profile
This profile covers Linde Inc based in Garland, Texas, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected March 31, 2014. Last inspected May 22, 2026.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 22, 2026 | Not classified | Human Drugs | 1318864 |
| March 31, 2014 | NAI | Human Drugs · Drug Quality Assurance | 872290 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Linde Inc
Stock ticker
LIN
Exchange
NASDAQ
Share price
$521.47
Market cap
$239.4B
Price as of
November 6, 2026
FEI Number
1650190
Address
2225 Lonnecker Dr, Garland, Texas 75041, United States
Country
United States
ID: a2fe0969-9e5b-48b8-982f-9ec3aaed91ee